Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07172802
What this trial is testing

GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancer (NSCLC)+3 more
GI Innovation, Inc. 102
Early research (Phase 1)Study completedNCT03758781
What this trial is testing

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerRecurrent CancerSolid Tumor+6 more
H. Lee Moffitt Cancer Center and Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT03469557
What this trial is testing

BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma, Gastric Carcinoma, Gastroesophageal Junction Carcinoma
BeiGene 30
Testing effectiveness (Phase 2)Looking for participantsNCT04370587
What this trial is testing

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorMelanomaHNSCC+3 more
ImmVira Pharma Co. Ltd 30
Testing effectiveness (Phase 2)UnknownNCT05783921
What this trial is testing

A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT04278092
What this trial is testing

Paclitaxel Plus Cetuximab After First-line Checkpoint Inhibitor Failure

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Medical University of Vienna 57
Early research (Phase 1)Looking for participantsNCT06912087
What this trial is testing

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous CellNeoplasm Recurrence, Local+3 more
University of Chicago 36
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Testing effectiveness (Phase 2)Looking for participantsNCT06876844
What this trial is testing

Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07354984
What this trial is testing

A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Early research (Phase 1)Study completedNCT04417465
What this trial is testing

First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 101
Testing effectiveness (Phase 2)Study completedNCT01045421
What this trial is testing

Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Who this might be right for
Advanced Nonhematological MalignanciesNon-Small Cell Lung CancerSmall Cell Lung Cancer+3 more
Millennium Pharmaceuticals, Inc. 273
Early research (Phase 1)Ended earlyNCT04628780
What this trial is testing

Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non-small-cell Lung CancerSquamous Cell Carcinoma of the Head and NeckRenal Cell Carcinoma+3 more
Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT02830594
What this trial is testing

Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Gastric AdenocarcinomaGastric Squamous Cell CarcinomaGastroesophageal Junction Adenocarcinoma+3 more
City of Hope Medical Center 14
Testing effectiveness (Phase 2)Study completedNCT04357873
What this trial is testing

Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

Who this might be right for
Squamous Cell Lung CancerVulvar CancerPenile Cancer+3 more
UNICANCER 112
Early research (Phase 1)Ended earlyNCT01528137
What this trial is testing

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+43 more
Stanford University 4
Not applicableLooking for participantsNCT06755762
What this trial is testing

Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer

Who this might be right for
Circulating Tumor CellHNSCC
Chang Gung Memorial Hospital 88
Testing effectiveness (Phase 2)Study completedNCT01577173
What this trial is testing

MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck

Who this might be right for
Head and Neck Cancer
Genentech, Inc. 122
Very early researchLooking for participantsNCT06828588
What this trial is testing

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Who this might be right for
Locally Advanced CancerMetastatic CancerHER2+2 more
Vanderbilt-Ingram Cancer Center 30
Next Page